Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies

• Autores principales: Shuanghui Yang (Autor), Huan Li (Autor), Ling Xu (Autor), Zhenhan Deng (Autor), Wei Han (Autor), Yanting Liu (Autor), Wenqi Jiang (Autor), Youli Zu (Autor)
• Formato: Libro
• Publicado: Elsevier, 2018-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Precision medicine has recently emerged as a promising strategy for cancer therapy because it not only specifically targets cancer cells but it also does not have adverse effects on normal cells. Oligonucleotide aptamers are a class of small molecule ligands that can specifically bind to their targe...